Akari Therapeutics (AKTX) Interest Expenses (2011 - 2026)

Akari Therapeutics (AKTX) posted quarterly Interest Expenses of $100000.0 for Q1 2026, little changed year-on-year from $100000.0 in Q1 2025, and up 9900.0% on a QoQ basis from $1000.0 in Q3 2025.

Akari Therapeutics (AKTX) Interest Expenses (2011 - 2026) Analysis & Trends

Akari Therapeutics (AKTX) has reported Interest Expenses for 14 consecutive years, with $100000.0 the latest figure, recorded in Q1 2026.

  • Quarterly Interest Expenses changed 0.0% year-over-year to $100000.0 in Q1 2026, while the trailing twelve-month figure through Mar 2026 was $201000.0 (down 99.29% YoY) and the FY2025 annual result came in at $63.4 million, up 5.0% from the prior year.
  • Interest Expenses climbed to $100000.0 in Q1 2026 per AKTX's latest filing, from $1000.0 in the prior quarter.
  • Over the last five years, Interest Expenses for AKTX reached as high as $42.2 million in Q4 2023 and fell as low as $1000.0 in Q3 2025.
  • A 5-year average of $11.7 million and a median of $100000.0 in 2025 frame the typical range for Interest Expenses.
  • Annual changes were most pronounced in 2023 — Interest Expenses gained 22.03% — and 2025, when it slumped 98.55%.
  • Year by year, Interest Expenses stood at $34.6 million in 2022, then climbed by 22.03% to $42.2 million in 2023, then plunged by 33.7% to $28.0 million in 2024, then sank by 100.0% to $1000.0 in 2025, then soared by 9900.0% to $100000.0 in 2026.
  • According to Business Quant data, Interest Expenses over the past three periods registered $100000.0, $1000.0, and $100000.0 for Q1 2026, Q3 2025, and Q2 2025 respectively.

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr) Interest Expense (Qtr)
1 Oculis Holding AG 68,785.72 Bn 68,785.72 Bn - -42,141.15
2 Nanobiotix 1,895.57 Bn 1,895.51 Bn - -
3 BeOne Medicines 471.35 Bn 466.56 Bn 1.35 Bn 32.89 Mn
4 NuCana 279.75 Bn 279.75 Bn - 16.81 Mn
5 Vertex Pharmaceuticals 120.24 Bn 113.00 Bn 2.59 Bn 420.30 Mn
6 Regeneron Pharmaceuticals 67.80 Bn 59.04 Bn 3.31 Bn 28.30 Mn
7 Belite Bio 62.51 Bn 62.51 Bn - -
8 Argenx Se 57.38 Bn 57.38 Bn 1.41 Bn -
9 Revolution Medicines 37.78 Bn 37.78 Bn - 1.17 Bn
10 Akari Therapeutics 86.55 Mn 86.55 Mn - 100,000.00

Historic Data

Download Data
DateValue
Mar 31, 2026 100,000.00
Mar 31, 2026 100,000.00
Sep 30, 2025 1,000.00
Sep 30, 2025 1,000.00
Jun 30, 2025 100,000.00
Jun 30, 2025 100,000.00
Mar 31, 2025 100,000.00
Mar 31, 2025 100,000.00
Dec 31, 2024 28.01 Mn
Dec 31, 2024 28.01 Mn
Sep 30, 2024 69,000.00
Sep 30, 2024 69,000.00
Dec 31, 2023 42.24 Mn
Dec 31, 2023 42.24 Mn
Jun 30, 2023 15,269.00
Jun 30, 2023 15,269.00
Dec 31, 2022 34.62 Mn
Dec 31, 2022 34.62 Mn
Dec 31, 2021 30.32 Mn
Dec 31, 2021 30.32 Mn